A system for metabolic activation of cyclophosphamide (CP), consisting of a crude microsomal fraction of mouse liver and necessary cofactors (S9 mix), was interfaced with three murine cell culture assays for immunotoxicity. These assays were: the Mishell-Dutton assay for in vitro antibody formation, splenic lymphocyte responsiveness to mitogens and bone marrow cell cultures. There was no effect of CP at doses up to 261 ,ug/ml (1mM) on any of the parameters measured unless S9 mix was included. Much greater potency was achieved if the S9 mix was prepared from livers of mice pretreated with phenobarbital. Under these conditions a doserelated inhibition of plaque-forming cells (PFC) in the Mishell-Dutton assay was observed, yielding an ED50 of 6.3 ,ug/ml. When splenic lymphocytes were exposed to CP in the presence of induced S9 mix, a dose related inhibition of the response to the B-cell mitogen, lipopolysaccharide (LPS), and to the T-cell mitogen, concanavalin A (Con A), was observed. For the optimum LPS concentration, the ED50 for CP was 8.1 ,ug/ml; for the optimum concentration of Con A, the ED50 was 6.7 ,ug/ml. DNA synthesis was not inhibited by the doses used. When bone marrow cells were exposed to CP in the presence of induced S9 mix, the stem cell population, enumerated by colonization in semisolid medium, was reduced in a dose-dependent manner, with an ED5 of 5.2 ,ug/ml. Again, DNA synthesis was not affected unless higher doses of CP were used.
In vitro assays for defining toxicological effects are becoming increasingly important as the burden ofnecessary investigations increases. Our laboratory has successfully interfaced a system for metabolic activation with several in vitro assays for immunotoxicity, thus widening the scope of these assays to include immunosuppressive agents which are not direct acting. Cyclophosphamide (CP) was chosen as a positive control in these assays since it requires metabolic activation (1) and is immunosuppressive in the mouse (2) .
Metabolic Activation System
A crude microsomal fraction was prepared from livers of male BALB/c mice to serve as a source of enzymes for metabolic activation. In some cases, the enzymes were induced with phenobarbital by placing 1 mg/ml in the animals' drinking water for 1 week until 24 hr prior to sacrifice by cervical dislocation. Livers were removed aseptically and homogenized in 3 ml of cold, sterile 1 .15% KCl/g liver. This homogenate was centrifuged at 9000g and the supernatant (S9 fraction) removed and frozen in 1 ml aliquots. When used, a tube of S9 was removed from storage at -70°C, thawed and added to a solution of cofactors. This S9 mix contained 3 mg S9 protein, 2 mM NADP, and 35 mM isocitrate in sterile culture medium and was added directly to cell suspensions, 0.1 ml/ml of cell suspension.
Mishell-Dutton Assay
The Mishell-Dutton in vitro antibody-producing assay has been found useful for recognizing immu- 
Splenic Lymphocyte Cultures
We have been using murine splenic lymphocyte cultures to assess immunotoxicity of a variety of chemicals. The parameters measured include effects on DNA synthesis and response of the lymphocytes to mitogens. The use of the S9 mix and effect of CP in this assay will be described.
Cell suspensions were prepared in RPMI 1640 by using spleens from male CD-1 mice, a random-bred albino from Charles River, which were 10-12 weeks of age. This strain is also being used in our laboratory for in vivo toxicological studies. Following collection of the cells by centrifugation, the pellet Environmental Health Perspectives FUdR and the 125I incorporation determined as described for DNA synthesis. Cell recovery was not affected by CP, even when S9 mix was included. This is illustrated graphically in Figure 1 . Viability, which was 91% in the control was also not changed by any of the treatments. DNA synthesis was also unaffected, as shown in Table 2 and Figure 1 . Data from other experiments which are not shown here indicate that CP in the presence of induced S9 inhibits DNA synthesis at higher doses than used in the experiment described.
Mitogenicity data are shown in Table 3 Table 3 gives the control values, and Figure 1 is a graphic representation of mitogen responsiveness when both CP and S9 are included in the 1-hr preincubation. A dose-dependent inhibition by CP is observed when S9 is included, and this inhibition occurs at lower doses if S9 from phenobarbital induced animals is used as the source of activating enzymes. The ED50 in this case is 8.1 ,ug/ml for LPS (5 ,ug/well) and 6.7 ,ug/ml for Con A (5 ,ug/well).
Bone Marrow Cultures
Immediately after removal of spleens from CD-1 mice, the hind limbs were removed and placed on ice. Using aseptic techniques, the femurs were trimmed and the contents flushed into a plastic centrifuge tube with a MEM (minimum essential medium) containing 10% fetal calfserum and adjusted to 3 x 106 cells/ml. Aliquots of 5 ml were placed in siliconized glass tubes, S9 mix and CP added where indicated, and the tubes incubated 1 hr in the roller drum as described for splenic lymphocytes. Cells were then collected by centrifugation and resuspended in a MEM with 10% fetal calf serum. Cell concentration and viability were determined, then the cells were adjusted to 3 x 106 cells/ml for determination of DNA synthesis as described for lymphocytes.
Viable stem cells were then enumerated by colonization in semisolid medium. For this determination, the cells were adjusted to 105 cells/ml in a MEM-containing 10% fetal calf serum, 5% horse serum, 1.8% methyl cellulose, and 10% L-cell conditioned medium. A 2-ml portion of suspension was placed in each of three wells in a six-well Linbro plate, and the plates incubated at 37°C, 10% C02, 95% humidity for 7-10 days. Colonies, defined as clusters of 25 cells or more, were then counted.
The results of a typical dose response experiment using S9 from both naive and phenobarbital induced animals are given in Table 4 . Cell yield was not affected by the treatment; viability was 91-93% in controls as well as all high dose samples. As shown in Table 4 , there was no inhibition of DNA synthesis at any dose of CP, even when S9 was included. Colony formation was affected; however, in a dose related manner when S9 from either naive animals or phenobarbital induced animals was included. Approximate ED50 values for the CP effect on stem cells are 20.8 ,ug/ml for uninduced S9 and 5.2 ,ug/ml for induced S9.
Discussion
In vitro activation of CP was first described in Ames' Salmonella microsome test for mutagenicity (8) . Since then, it has been used as a model compound in other, more sophisticated mammalian in vitro assays. Stetka and Wolff were able to induce sister chromatid exchanges in cultured Chinese hamster ovary cells by including rat liver microsomes with CP (9) . Recently, an in vitro teratogenic assay was described in which CP induced defects when an hepatic microsomal fraction was included (10) . The present report extends use of in vitro activation of CP into the area of immunotoxicology.
A system for metabolic activation of CP in vitro has been successfully interfaced with three cell culture assays for immunotoxicity. A summary of the effects of CP when activated by an S9 mix from phenobarbital induced animals is given in Table 5 . The approximate ED50 values for specific end points in the three assays are very similar, ranging from 5.2 to 8.1 p,g/ml or 2.0 to 3.1 x 1OM. It is important to note that DNA synthesis is inhibited only when much higher doses of CP are used. The utility of the described assays is tremendously increased by inclusion of the S9 mix, in that they can now be used for screening for immunotoxicity, as well as elucidation of mechanisms of action. As with all in vitro assays, it is important to keep the information in context with in vivo effects.
